UCSF Medical Center Antimicrobial Susceptibility: Pseudomonas aeruginosa 2015

PrintPrintPDFPDF

The table below details the percent susceptibility of inpatient isolates of Pseudomonas aeruginosa to single agents and to the combination of antimicrobials indicated (number to the right of the arrow).  Excludes cystic fibrosis isolates.  Data are from 2015.

 MER=meropenem; TOB=tobramycin; PIPTAZ=piperacillin/tazobactam; CFPM=cefepime; CIP=ciprofloxacin

 

MER -->

MER+TOB

PIPTAZ -->

PIPTAZ+TOB

CFPM -->

CFPM+TOB

MER --> MER+CIP

PIPTAZ  -->

PIPTAZ+CIP

CFPM -->

CFPM+CIP

All Patients

79%--> 97%

75% --> 97%

86% --> 97%

79% --> 91%

75% --> 97%

86% --> 97%

ICU

77% --> 93%

71% --> 93%

81% --> 93%

77% --> 82%

71% --> 82%

81% --> 84%

Floor

81% --> 97%

76% --> 98%

90% --> 99%

81% --> 90%

83% --> 91%

90% --> 91%